Springboard Enterprises Announces Inaugural 2024 Healthcare and Technology Accelerator Program Cohort
The 2024 Accelerator Program Features Nine Women Driving Transformational Health Solutions WASHINGTON, DC, UNITED STATES, September 11, 2024 /EINPresswire.com/ — Springboard Enterprises, a leader in fostering women-led innovation, is proud to announce its 2024 Healthcare and Technology Cohort. The nine selected companies, led by innovative female founders, are addressing key areas in healthcare such as cancer […]
Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
BOSTON–(BUSINESS WIRE)–Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker(Nasdaq: BRKR), to develop the world’s first clinical diagnostic tests that leverage multi-parametric, single-cell biophysical markers and machine learning. Based on cellular biophysical markers attained using Bruker’s advanced atomic […]
LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown
For the past year, Jean Pham and a pair of employees at her three-year-old company, Cellens, shared high-tech research instruments with scores of other scientists under a LabCentral program aiding startups owned by women and people of color.MATTHEW J. LEE/GLOBE STAFF With funding constrained, some biotech startups are staying longer in shared space CAMBRIDGE — […]
CELLENS IS ON SOSV HUMAN HEALTH 100 LIST
Welcome to the second annual SOSV Human Health 100. The list captures SOSV’s 100 most exciting companies in human health as of April 2023. SOSV’s core mission, which we pursue through our IndieBio, HAX, and Orbit startup development programs, is to fund and foster startups that will improve human and planetary health. In addition to the Human Health 100, […]
CELLENS WON GOLDEN TICKET IGNITE AWARD
CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — LabCentral Ignite, with support from key sponsors Pfizer, Bristol Myers Squibb and Mission BioCapital, today announced the winners of its second annual Golden Ticket contest: Cellens, Guardian Bio, QurCan Therapeutics and Spheric Bio. The winners were unveiled at LabCentral Ignite’s bioDiversity Summit & Awards, a new annual event that brings the entire biotech ecosystem together to discuss […]
2021 | ATOMIC FORCE MICROSCOPY DETECTS THE DIFFERENCE IN CANCER CELLS OF DIFFERENT NEOPLASTIC AGGRESSIVENESS VIA MACHINE LEARNING
A novel method based on atomic force microscopy (AFM) working in Ringing mode (RM) to distinguish between two similar human colon epithelial cancer cell lines that exhibit different degrees of neoplastic aggressiveness is reported on. The classification accuracy in identifying the cell line based on the images of a single cell can be as high […]
2018 | NONINVASIVE DIAGNOSTIC IMAGING USING MACHINE-LEARNING ANALYSIS OF NANORESOLUTION IMAGES OF CELL SURFACES: DETECTION OF BLADDER CANCER
We report an approach in diagnostic imaging based on nanoscale-resolution scanning of surfaces of cells collected from body fluids using a recent modality of atomic force microscopy (AFM), subresonance tapping, and machine-leaning analysis. The surface parameters, which are typically used in engineering to describe surfaces, are used to classify cells. The method is applied to […]
2009 | AFM DETECTS DIFFERENCES IN THE SURFACE BRUSH OF NORMAL AND CANCEROUS CERVICAL CELLS
The atomic force microscope is broadly used to study the morphology of cells but it can also probe the mechanics of cells. It is now known that cancerous cells may have different mechanical properties than normal cells but the reasons for these differences are poorly understood. Here we report quantitatively the differences between normal and […]
CELLENS & TUFTS UNIVERSITY TO RECEIVE “BITS TO BYTES” AWARD FROM BAKER-POLITO ADMINISTRATION AND THE MASSACHUSETTS LIFE SCIENCES CENTER
Fourteen projects receiving funding to support R&D, innovation in addressing challenges in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions. Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced more than $18 million in capital funding to support 14 projects by advancing life sciences R&D, innovations […]
Terms of Usage
Last updated September 22, 2023 AGREEMENT TO OUR LEGAL TERMS We are Cellens Inc. (“Company,” “we,” “us,” “our“). We operate the website https://cellensinc.com (the “Site“), as well as any other related products and services that refer or link to these legal terms (the “Legal Terms“) (collectively, the “Services“). You can contact us by email at […]
